Arcadia Biosciences, Inc. (RKDA) Files Form 4 Insider Selling : Steven F. Brandwein Sells 8,280 Shares

Arcadia Biosciences, Inc. (RKDA): Steven F. Brandwein , Interim Chief Financ. Officer of Arcadia Biosciences, Inc. sold 8,280 shares on Jun 13, 2016. The Insider selling transaction was reported by the company on Jun 15, 2016 to the Securities and Exchange Commission. The shares were sold at $2.49 per share for a total value of $20,645.35 , the company said in a SEC Form 4 Filing.

Other Insider transactions have been reported by the company according to SEC Form 4, on Apr 27, 2016, Steven F. Brandwein (Interim Chief Financ. Officer) sold 1,720 shares at $2.42 per share price.On Apr 6, 2016, Vic C. Knauf (Chief Scientific Officer) sold 2,853 shares at $2.98 per share price.Also, On Feb 3, 2016, Eric J. Rey (President and CEO) sold 3,200 shares at $2.86 per share price.On Sep 14, 2015, Don Emlay (VP Regulatory and Compliance) sold 3,521 shares at $5.00 per share price.

Shares of Arcadia Biosciences Inc (RKDA) ended Wednesday, Jun 15, 2016 session in red amid volatile trading. The shares closed down -0.07 points or -2.86% at $2.38 with 80,756 shares getting traded. Post opening the session at $2.55, the shares hit an intraday low of $2.35 and an intraday high of $2.68 and the price vacillated in this range throughout the day. The company has a market cap of $105 M and the number of outstanding shares has been calculated to be 4,42,52,896 shares. The 52-week high of Arcadia Biosciences Inc is $8.65 and the 52-week low is $1.1.

Arcadia Biosciences Inc Money Flow Index Chart

Arcadia Biosciences Inc. is an agricultural biotechnology trait company. The Company has a portfolio of late-stage yield and product quality traits addressing multiple crops that supply the food and feed markets. The Company’s traits are focused on enhancements that increase crop yields by enabling plants to manage environmental and nutrient stresses. The Company has over 50 products in development using its traits and there are 13 in advanced stages of development or on the market. Its crop yield traits are utilized by its commercial partners to develop higher yielding seeds for crops including wheat rice soybean corn and sugarcane as well as for other crops such as cotton canola turf and trees. The Company uses both (genetically modified) GM and non-GM technologies to develop its traits.

Leave a Reply

Arcadia Biosciences Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Arcadia Biosciences Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.